These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 1763542

  • 1. Quinolone-cation interactions: a review.
    Lomaestro BM, Bailie GR.
    DICP; 1991 Nov; 25(11):1249-58. PubMed ID: 1763542
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Drug interactions with quinolone antibacterials.
    Brouwers JR.
    Drug Saf; 1992 Nov; 7(4):268-81. PubMed ID: 1524699
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Fluoroquinolones: interaction profile during enteral absorption.
    Deppermann KM, Lode H.
    Drugs; 1993 Nov; 45 Suppl 3():65-72. PubMed ID: 7689454
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Interaction of divalent cations, quinolones and bacteria.
    Marshall AJ, Piddock LJ.
    J Antimicrob Chemother; 1994 Oct; 34(4):465-83. PubMed ID: 7868402
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Steady-state kinetics of the quinolone derivatives ofloxacin, enoxacin, ciprofloxacin and pefloxacin during maintenance treatment with theophylline.
    Wijnands WJ, Vree TB, Baars AM, van Herwaarden CL.
    Drugs; 1987 Oct; 34 Suppl 1():159-69. PubMed ID: 3481317
    [Abstract] [Full Text] [Related]

  • 12. Update on quinolone drug interactions.
    Hulisz D, Miller K.
    Am Pharm; 1990 Sep; NS30(9):34-6. PubMed ID: 2220561
    [Abstract] [Full Text] [Related]

  • 13. Effects of order of magnesium exposure on the postantibiotic effect and bactericidal activity of ciprofloxacin.
    Li RC, Lo KN, Lam JS, Lau PY.
    J Chemother; 1999 Aug; 11(4):243-7. PubMed ID: 10465124
    [Abstract] [Full Text] [Related]

  • 14. Overview of drug interactions with the quinolones.
    Davey PG.
    J Antimicrob Chemother; 1988 Sep; 22 Suppl C():97-107. PubMed ID: 3053579
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Overview of the fluoroquinolone antibiotics.
    Just PM.
    Pharmacotherapy; 1993 Sep; 13(2 Pt 2):4S-17S. PubMed ID: 8386356
    [Abstract] [Full Text] [Related]

  • 18. In-vitro activity of newer quinolones against aerobic bacteria.
    Auckenthaler R, Michéa-Hamzehpour M, Pechère JC.
    J Antimicrob Chemother; 1986 Apr; 17 Suppl B():29-39. PubMed ID: 2940214
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The pharmacokinetics and tissue penetration of the fluoroquinolones.
    Bergeron MG.
    Clin Invest Med; 1989 Feb; 12(1):20-7. PubMed ID: 2920479
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.